2,252
Views
4
CrossRef citations to date
0
Altmetric
Articles

Risk of hepatitis B virus reactivation following ruxolitinib treatment in patients with myeloproliferative neoplasms

, ORCID Icon, &

Reprints and Permissions

This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, reproduction in any medium, provided the original work is properly cited.

You are not required to obtain permission to reuse this article in part or whole.